Phase I Study of SHR7390 in Patients With Advanced Solid Tumors

NCT02968485 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: SHR7390

Sponsor

Jiangsu HengRui Medicine Co., Ltd.